Alvotech S.A. - ALVO Earnings per share for the trailing year

Public company logo of Alvotech Corp (ALVO)

Alvotech (ALVO) is a specialized biosimilar developer with robust scientific potential in oncology and immunology. The GURU.Markets system provides the current EPS YoY TTM growth rate, where -417.30 represents the latest level of this metric. Process optimization via external contractors and logistics accelerates the rollout of affordable, budget-friendly therapies to global markets, reducing the cost of treating complex pathologies.

alvotech.com (ALVO): Earnings per share for the last twelve months from 02/11/2024 to 11/14/2026

ALVO (Alvotech Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Price alvotech.com|ALVO - Analyst Consensus Forecast
- issuer market value details:
Market Value Alvotech S.A.|ALVO - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Alvotech|ALVO - Company Book Value|Market Value to Book Value alvotech.com|ALVO - Company Total Assets
- company total debt and liquidity indicators:
Total Debt to Capital Alvotech|ALVO - Long-Term Debt to Equity|Short-Term Debt to Equity Alvotech Biopharmaceuticals|ALVO - Company Total Debt|Debt to Book Capitalization Ratio Alvotech S.A.|ALVO - Company Long-Term Debt|Short-Term Debt Alvotech|Intermediate Liquidity Ratio alvotech.com
- net income and valuation ratios data:
ALVO - Net Profit|Expected Net Profit Alvotech|ALVO - P/E Multiple|Projected Price to Earnings Alvotech S.A.|ALVO - PEG Multiple|Business Value to Operating Income Before Depreciation Alvotech S.A.|ALVO - Operating profit EBITDA|Net earnings per share (EPS TTM) Alvotech|ALVO - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months alvotech.com|ALVO - Net earnings per share growth this year|Net earnings per share growth forecast for next year Alvotech
- revenue and sales details:
ALVO - Company Revenue|Company Expected Sales Volume alvotech.com|ALVO - Price-to-Revenue Ratio|Future Price to Revenue Alvotech S.A.
Fundamental valuation:alvotech.com - ALVO
Mass-produced product of Alvotech Biopharmaceuticals

Alvotech's ability to develop affordable biosimilars depends directly on overcoming patent barriers and securing regulatory approvals, which renders profits highly volatile. By analyzing the historical net income per share growth rate YoY ttm, an investor can observe the percentage change in EPS over the last 12 months, where peak values often signal that the asset is overvalued against a backdrop of high production costs.

Competitor analysis

haleon.com - Earnings per share for the last four quarters|KVUE: Net earnings per share (EPS TTM)|Verona Pharma PLC - Earnings per share for the trailing year|MENS (Jyong Biotech Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Ligand Corp LGND|Earnings per share for the last twelve months Amneal Pharmaceuticals (AMRX)|PRGO (perrigo.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) LQDA (Liquidia)|Net earnings per share (EPS TTM) Galapagos N.V. GLPG|ANIP - Earnings per share for the last twelve months|MNKD: Earnings per share for the last twelve months|AMPH (Amphastar Pharmaceuticals) - Net earnings per share for the last 12 months|PCRX (pacira.com) - Earnings per share for the last twelve months|Earnings per share for the last twelve months ARS Pharmaceuticals, Inc.|Net earnings per one share for the last twelve months Theravance Biopharma Inc TBPH|Net earnings per share for the last 12 months AQST (Aquestive Pharma)|Earnings per share for the last four quarters SCPH|Net earnings per share (EPS TTM) TECX (Tectonic Therapeutic)|tonixpharma.com (TNXP) - Net earnings per one share for the last twelve months|SXT China - Net earnings per share (EPS TTM)|Eupraxia Pharmaceuticals (EPRX) - Net earnings per share for the last 12 months|BHST: Net earnings per share (EPS TTM)|Invizyne - Earnings per share for the trailing year|ORMP (Oramed) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Entera Bio Corp|Earnings per share for the last twelve months MindWalk Holdings Inc. (HYFT)|Earnings per share for the last twelve months ABVC (ABVC BioPharma Inc.)|Cumberland Pharma - Net earnings per share for the last 12 months|Quantum BioPharma Corp - Earnings per share for the last twelve months|FGEN - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months telomirpharma.com|ranitherapeutics.com (RANI) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months SNYR (Synergy CHC)|RLYB (Rallybio Corp) - Net earnings per share (EPS TTM)|LEXX: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PULM|Net earnings per share (EPS TTM) ftzy.com.cn (PTHL)|Earnings per share for the last twelve months Aptorum Group APM|Earnings per share for the trailing year LYRA|IBO - Earnings per share for the last twelve months|TNF Pharmaceuticals (TNFA) - Net earnings per share for the last 12 months|YCBD: Net earnings per share (EPS TTM)|painreform.com (PRFX) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months CYTO|LIPO: Earnings per share for the trailing year|Earnings per share for the last twelve months Optinose (OPTN)|PIRS - Net earnings per one share for the last twelve months|Procaps Group S.A. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters PTPI (petrospharma.com)|Qilian International Holding - Net earnings per share (EPS TTM)|Earnings per share for the trailing year SLRN (Acelyrin Inc.)|TFFP: Net earnings per share (EPS TTM)